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A B S T R A C T 
Excessive glutamate release following traumatic spinal cord injury (SCI) has been associated with exacerbating 
the extent of SCI. However, the mechanism behind sustained high levels of extracellular glutamate is unclear. 
Spinal cord segmentsmounted in a sucrose double gap recording chamber are an establishedmodel for traumatic 
spinal cord injury. We have developed a method to record, with micro-scale printed glutamate biosensors, 
glutamate release from ex vivo rat spinal cord segments following injury. This protocol would work equally well 
for similar glutamate biosensors. 
© 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http:// 
creativecommons.org/licenses/by/4.0/). 
A R T I C L E I N F O 
Protocol name: Electrochemical Glutamate Sensing from Resected Spinal Cord Segment 
Keywords: Biosensor, SCI, Excitotoxicity, Direct ink writing, Additive manufacturing, Rapid prototyping, Implantable 
Article history: Received 14 June 2019; Accepted 5 August 2019; Available online 23 August 2019 
Specifications Table 
Subject Area: Neuroscience 
More specific subject Glutamate Excitotoxicity and Its Role in Spinal Cord Injury 
area: 
Protocol name: Electrochemical Glutamate Sensing from Resected Spinal Cord Segment 
Reagents/tools:  
* Corresponding author. 
E-mail address: hwlee@purdue.edu (H. Lee). 
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2215-0161/© 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http:// 
creativecommons.org/licenses/by/4.0/). 
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Bio-Logic SP-200 Potentiostat (Bio-Logic, Knoxville, TN, USA): https://www.bio-logic.net/ 
products/multichannel-conductivity/sp-200-potentiostat-galvanostat/ 
 EC-Lab1 V11.02 software (Bio-Logic, Knoxville, TN, USA): https://www.bio-logic.net/softwares/ 
ec-lab-software/#1461666531286-9f792007-63fe 
 RE-5B Ag/AgCl (3M NaCl) reference electrode (BASi, Part No. MF-2052, West Lafayette, IN, USA): 
https://www.bio-logic.net/softwares/ec-lab-software/#1461666531286-9f792007-63fe 
 Ag/AgCl ink (Engineered ConductiveMaterials, Inc., Part No. CI-4001, Delaware, OH): http://www. 
conductives.com/biosensors.php 
 Pt auxiliary electrode (BASi, Part No. MW-4130, West Lafayette, IN, USA): https://www.basinc. 
com/products/813 
 Hook test lead wires (E-Z Hook, Arcadia, CA, USA): https://catalog.e-z-hook.com/viewitems/test-
leads/e-z-micro-hook-test-leads-2 
 L-glutamic acid, 99+% (Alfa Aesar, Stock # A15031, Tewksbury, MA, USA): https://www.alfa.com/ 
en/catalog/A15031/ 
 L-ascorbic acid, 99% (Sigma-Aldrich, Product # A92902, St. Louis, MO, USA): https://www. 
sigmaaldrich.com/catalog/product/sial/a92902?lang=en&region=US 
 Phosphate-buffered saline (PBS), 10X (0.1M) pH 7.4 (Thermo Fisher Scientific, Cat. # AM9625, 
Waltham, MA, USA): https://www.thermofisher.com/order/catalog/product/AM9625 
 Cimarec+TM stirring hotplate (Thermo Fisher Scientific, Cat. # SP88857107, Waltham, MA, USA): 
https://www.thermofisher.com/order/catalog/product/SP88857107?SID=srch-srp-SP88857107 
 1Mil Kapton1 tape (polyimide tape) (Kapton Tape, Part # KPT-1/4, Torrance, CA, USA): https:// 
www.kaptontape.com/1_Mil_Kapton_Tapes.php 
 Micromanipulator (Newport, 433 series, Irvine, CA, USA) (Fig. 2) 
 Double sucrose gap recording chamber (Fig. 2) 
 Minipuls 3 peristaltic pump (Gilson, Middleton, WI, USA): https://www.gilson.com/system-
minipuls-3-peristaltic-pumps.html 
 Fine point forceps (Thermo Fisher Scientific, Cat. # 12-000-122, Waltham, MA, USA): https:// 
www.fishersci.com/shop/products/high-precision-straight-tapered-ultra-fine-point-tweezers-
forceps/12000122 
Experimental design: A spinal cord segment was isolated from a rat and maintained in oxygenated Krebs solution. A 
biosensor was inserted into the spinal cord and recorded glutamate concentration while the spinal 
cord was compressed to simulate injury. 
Trial registration: n/a 
Ethics: All animals were used according to the Purdue University Animal Care and Use Committee protocol 
and guidelines. 
Value of the Protocol 
 Glutamate biosensor measures in real time with better spatial and temporal resolution than microdialysis 
 Measuring from the spinal cord ex vivo removes processes and variables, such as hemorrhage and ischemia, that may 
obscure glutamate release 
 The glutamate biosensors used were made by direct writing of nanocomposite ink, which is an easy and fast fabrication 
method in comparison to conventional micro-fabrication 
Description of protocol 
This protocol records extracellular glutamate with high spatial (100mm) and temporal (1 s) 
resolution from a spinal cord segment during injury [1,2]. Glutamate release following traumatic 
spinal cord injury (SCI) exacerbates the extent of SCI [3], yet the mechanism behind sustained high 
levels of extracellular glutamate has remained unclear. This protocol can be used to study the 
relationship between extracellular glutamate and other molecules, such as acrolein, and develop 
therapeutic interventions [4]. 
Materials 
 Bio-Logic SP-200 Potentiostat (Bio-Logic, Knoxville, TN, USA) 
 EC-Lab1 V11.02 software (Bio-Logic, Knoxville, TN, USA) 
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 RE-5B Ag/AgCl (3M NaCl) reference electrode (BASi, Part No. MF-2052, West Lafayette, IN, USA) 
 Ag/AgCl ink (Engineered Conductive Materials, Inc., Part No. CI-4001, Delaware, OH) 
 Pt auxiliary electrode (BASi, Part No. MW-4130, West Lafayette, IN, USA) 
 Hook test lead wires (E-Z Hook, Arcadia, CA, USA) 
 L-glutamic acid, 99+% (Alfa Aesar, Stock # A15031, Tewksbury, MA, USA) 
 L-ascorbic acid, 99% (Sigma-Aldrich, Product # A92902, St. Louis, MO, USA) 
 Phosphate-buffered saline (PBS), 10X (0.1M) pH 7.4 (Thermo Fisher Scientific, Cat. # AM9625, 
Waltham, MA, USA) 
 Cimarec+TM stirring hotplate (Thermo Fisher Scientific, Cat. # SP88857107, Waltham, MA, USA) 
 1Mil Kapton1 tape (polyimide tape) (Kapton Tape, Part # KPT-1/4, Torrance, CA, USA) 
 Krebs solution (124mM NaCl, 2mM KCl, 1.24 mM KH2PO4, 26mM NaHCO3, 10mM ascorbic acid, 
1.3 mM MgSO4, 1.2 mM CaCl2, 10mM glucose, bubbled continuously with 95% O2, 5% CO2, to 
maintain pH 7.2–7.4) 
 Ketamine 
 Xylazine 
 Male Sprague-Dawley rat, 200–400 g (Envigo RMS, Inc., Indianapolis, IN) 
 Double sucrose gap recording chamber (Fig. 2) 
 Micromanipulator (Newport, 433 series, Irvine, CA, USA) (Fig. 2) 
 Minipuls 3 peristaltic pump (Gilson, Middleton, WI, USA) 
 Fine point forceps (Thermo Fisher Scientific, Cat. # 12-000-122, Waltham, MA, USA) 
Protocol 
1 Calibrate biosensor [1] to glutamate. 
a Prepare 50mL 0.01M PBS in a 100-mL beaker and heat to 37 C. 
b Add magnetic stir bar to PBS and stir at about 200 rpm. 
c Place biosensor, RE-5B Ag/AgCl reference electrode and auxiliary electrode in the PBS. 
d Apply 0.5 V to the biosensor (working electrode) versus the reference electrode (amperometry). 
e Wait at least 20min after applying the 0.5 V potential for non-Faradaic current to decrease. 
f Add 50mM glutamate (50mL of 50mM glutamate) three times and wait for the current to settle 
between each time. 
g Add200mMglutamate (200mL of 50mMglutamate) two times andwait for the current to settle 
between each time. The result of steps 1f–g is a five-point calibration at 50,100,150, 350 and 550 
mM glutamate) (Fig. 1). 
h When finished, wash the glutamate biosensor with fresh 0.01M PBS and store the biosensor in 
0.01M PBS before use later in the protocol. 
Notes 
2 Information on our glutamate biosensor is included in the supplementary material section. 
3 If using a different glutamate biosensorwith this protocol,make sure that it also is selective against 
ascorbic acid [1,5,6]. 
4 The staircase current response of the biosensor to glutamate is used to create a calibration line of 
sensitivity to glutamate. 
5 Surgically extract spinal cord [2]. 
a Anesthetize the animal with a mixture of ketamine (80mg/kg) and xylazine (10mg/kg) through 
intraperitoneal injection. 
b Transcardially perfuse the animal with cold oxygenated Krebs solution. 
c Rapidly remove the vertebrae column. 
d Perform complete laminectomy. 
e Carefully cut spinal roots to isolate the spinal cord. 
f Remove the dura mater to make insertion of the glutamate biosensor easier. 
g Subdivide the spinal cord twice longitudinally to obtain ventral white matter strips (spinal cord 
segments). 
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Fig. 1. Current density vs. time during calibration of our glutamate biosensor prior to ex-vivo measurement (50, 100, 150, 350, 
and 550mMglutamate). The insert to the right contains the signal step from addition of 50mMglutamate, which shows the fast 
response of our glutamate biosensors. 
Note: We used animals under strict accordance to the Purdue University Animal Care and Use 
Committee protocol and guidelines. 
6 Incubate spinal cord segments in fresh Krebs solution for 60min at room temperature. 
Note: Spinal cord segments can be kept Krebs solution perfused with O2 for up to 4 h. 
7 Place spinal cord segment into a double sucrose gap recording chamber (Figs. 2 and 3a). 
a Place the spinal cord segment across the central compartment, sucrose gap compartments and 
outside wells. 
Fig. 2. (a) Photograph of double sucrose gap recording chamber, Plexiglass arm for holding the glutamate biosensor and the 
micromanipulator for controlling vertical movement of the glutamate biosensor. The glutamate biosensor is not attached to the 
arm in this photograph. (b) The glutamate biosensor has been attached to the plexiglass arm, and a white matter strip (spinal 
cord) has been placed in the sucrose gap recording chamber. 
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Fig. 3. (a) Photograph of glutamate biosensor inserted into a rat spinal cord segment in a double sucrose gap recording chamber. 
Important components of the system are labeled. (b) Photograph of compressing the spinal cord with forceps to simulate 
compression injury. 
b Continuously perfuse central compartment with 2mL/min 37 C oxygenated Krebs solution 
using peristaltic pump. 
8 Mount a pseudo-Ag/AgCl reference electrode [1] and Pt auxiliary electrode to the sidewalls of the 
central compartment of the recording chamber, so they sick into the Krebs solution as shown in 
Fig. 3a. 
Notes: 
9 Information on making a pseudo-Ag/AgCl electrode is included in the supplementary material 
section. 
10 Wemeasured76mV as the potential of the pseudo Ag/AgCl electrode vs. the BASi RE-5B Ag/AgCl 
reference electrode. 
11 Polyimide tape was used to secure the pseudo-Ag/AgCl reference and auxiliary electrodes to the 
recording chamber. 
12 Attach glutamate biosensor (working electrode) to the Plexiglass arm above the recording 
chamber with tape. 
13 Using amicromanipulator, lower the Plexiglass armwith the glutamate biosensor attached (Fig. 2), 
so the glutamate biosensor sticks 1–1.5 mm into the spinal cord segment. 
Note: Although the 50-mm thick liquid crystal polymer biosensor shank is flexible compared to 
silicon and ceramic, we were able to insert these shanks 1–1.5 mm into the spinal cord segment. 
We tested implantation before ex-vivo implantation with 0.6% agarose gel, a model for device 
insertion into brain tissue [7]. 
14 Connect working, reference and counter electrodes to the potentiostat with test hook clips. 
15 Apply +0.5 V to the working electrode versus the pseudo-Ag/AgCl reference electrode and record 
current. 
Note: The choice of holding potential depends on the electrochemical sensor used. Applying +0.5 V 
vs. Ag/AgCl is an adequate holding potential oxidase/Pt-based electrochemical biosensors [1,8,9]. 
Another holding potential typically used for this class of biosensors is +0.7 V vs. Ag/AgCl. 
16 Wait at least 20min (1200 s) after applying the 0.5 V potential for non-Faradaic current to decrease. 
17 At 20min (1200 s), simulate spinal cord injury by compressing about 70N with forceps for 5 s at 
the part of the spinal cord segment immediately in front of where the glutamate biosensor is 
inserted (Fig. 3b). 
Notes: 
18 70N corresponds to about 70% of one’s maximum pinching force [10]. 
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Fig. 4. Validation of ex vivo glutamate measurement following injury in spinal cord segment of a rat. The printed micro-scale 
glutamate biosensors were inserted into spinal cord white matter strips before injury. At 20min (1200 s) we injured the spinal 
cord by compressing it about 70N (70%max strength) with forceps for 5 s at the part of the spinal cord segment immediately in 
front of where the glutamate biosensor is inserted. At 40min (2400 s) we used a micropipette to inject 100mL or 50mM 
glutamate at the same location as injury. (a)At 60min (3600 s)we repeated injury at the same location. Each subfigure shows an 
independent experiment from a different white matter strip from the same animal on the same day. 
19 Compressing the spinal cord for more than 10 s risks breaking it in two. 
20 For comparison, at 40min (2400s) use amicropipette to inject 100mL 50mM glutamate at the site 
of injury. 
Protocol validation 
Using this method, we measured spikes in glutamate concentration following injury of half 
segment of rat spinal cord ex vivo. Fig. 4 shows these measurements. 
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Appendix A. Supplementary data 
Supplementarymaterial related to this article can be found, in the online version, at doi:https://doi. 
org/10.1016/j.mex.2019.08.008. 
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